ONEMEDNET CORPORATION Contingent Consideration Classified as Equity, Fair Value Disclosure
ONEMEDNET CORPORATION (ONMD) had Contingent Consideration Classified as Equity, Fair Value Disclosure of $300.00 thousand as of 2025-12-31, per its S-1/A filed 2026-07-08.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure · last filed 2026-07-08
- 2025-12-31: Contingent Consideration Classified as Equity, Fair Value Disclosure $300.00K.
- 2025-09-30: Contingent Consideration Classified as Equity, Fair Value Disclosure $300.00K.
- 2025-06-30: Contingent Consideration Classified as Equity, Fair Value Disclosure $200.00K.
| Period end | Contingent Consideration Classified as Equity, Fair Value Disclosure |
|---|---|
| 2025-12-31 | $300.00K S-1/A · filed 2026-07-08 |
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $200.00K 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |